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E-mail address: tisogai@mol.f.u-tokyo.ac.jp (T. IsogWe analyzed the mRNA diversity of genes after inducing neuronal differentiation in human NT2
teratocarcinoma cells using all-trans retinoic acid (RA). DNA microarray analyses of cells treated
with RA identiﬁed 358 RA-responsive genes. mRNA diversity analysis revealed that 274 genes pro-
duced multiple protein-coding transcripts by alternative splicing. Among these 274 genes, we chose
26 genes that showed AS in their C-terminus and 12 transcription factor genes for further analysis.
By using transcript-speciﬁc primers, we performed quantitative real-time PCR analysis to examine
the expression proﬁles of all the protein-coding transcripts. Consequently, we identiﬁed genes
which showed different RA-induced changes in the expression of their protein-coding transcripts.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction enzymatic activities [3]. Several important events during neuronalOne of the most important prerequisites for understanding the
functions of genes is to analyze mRNA diversity. Several genome
research and high-throughput sequencing studies suggest that at
least 70% of all human genes produce multiple transcripts by alter-
native splicing (AS) [1,2]. Accordingly, AS of a single gene could
produce multiple protein-coding transcripts, each exhibiting
different properties, intracellular localization and regulation ofchemical Societies. Published by E
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ai).development, including aspects of cell-fate determination, axon
guidance and synaptogenesis, are controlled by AS [4], suggesting
that AS might be prevalent in the mammalian nervous system.
For example, a switch from PTB to nPTB expression during neuro-
differentiation has been implicated in regulating neuronal AS [5].
Various studies have also identiﬁed brain-speciﬁc splicing factors,
such as NOVA1 that regulates neuron-speciﬁc AS and is essential
for neuronal viability [6,7]. Obviously, such information on mRNA
diversity would be important for understanding the mechanism of
neurodifferentiation, and could ultimately provide therapeutic
solutions for neural degenerative diseases, such as Parkinson’s
and Alzheimer’s diseases. Although the importance of analyzing
mRNA diversity in the nervous-system development and function
is becoming apparent, the mechanism controlling the neuronal
AS has remained unclear. Previously, we sequenced about 55 thou-
sand human full-length cDNAs and about 1.45 million 50-end se-
quences (50-EST) from human cDNA libraries constructed by
oligo-capping method [8–11] for gene function analysis. Our previ-
ous results suggested a close relationship between the predicted
function of a gene and its tissue-speciﬁc expression [11]. We also
constructed the FLJ Human cDNA Database (http://ﬂj.lifesci-
encedb.jp) [11], which would be very useful in analyzing the diver-
sity of protein-coding transcripts. Additionally, we found a close
relationship between the predicted function of a gene and itslsevier B.V. All rights reserved.
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into an appropriate transcript according to the need and circum-
stance. However, in our previous study [11], we were unable to dis-
tinguish whether the observed changes in the gene expression
pattern was associated with the genetic or the environmental risk
factors, primarily because the tissues used in our previous analyses
were not derived from one individual. In the present study, we
used NT2 cells, also known as NT2/D1, pluripotent human embry-
onal carcinoma cell lines, for analyzing mRNA diversity. This cell
line is a goodmodel for the embryonic development studies as well
as for the tumor cell differentiation studies. In response to all-trans
retinoic acid (RA), NT2 cells differentiate towards a neuronal line-
age with associated loss of cell growth and tumorigenicity [12]. Be-
cause these cells shared same genetic background, we were able to
analyze changes in the mRNA diversity of genes following changes
in an environmental condition, namely, stimulation with RA. Thus,
our efforts to identify RA-responsive genes and to analyze mRNA
diversity have led to various ﬁndings on neurodifferentiation.
Here, we have used the DNA microarray technique to globally
analyze genes in the NT2 cells whose expression levels changed
when cells were treated with RA. We have also used the FLJ Human
cDNA Database to explore correlations between the mRNA diver-
sity of gene and gene function. Finally, we have identiﬁed the pro-
tein-coding transcripts generated from selected each one of the
selected 38 genes, and examined their expression proﬁles by
real-time PCR analysis.
2. Materials and methods
2.1. Cell culture and RNA isolation
NT2 cell line was purchased from STRATAGENE (CA, USA) [12]
and was cultured according to the recommendations of the
supplier. The stock solution (10 mM) of RA (SIGMA, MO, USA) was
prepared in dimethyl sulfoxide. On day 0, the culture medium
was replaced with fresh medium containing 10 lM RA. After 24,
48, and 168 h incubationwith RA,we collected the cells for RNA iso-
lation and designated them as 1-day, 2-day and 7-day samples,
respectively. The 0-day sample (cells immediately before the addi-
tion of RA) was used as the control. Total RNAs were extracted from
these cells using the ISOGEN Reagent (Nippongene, Tokyo, Japan).
Subsequently, polyA(+) RNAs were isolated from each total RNA
sample using a MicroPoly(A) Purist Kit (Life Technologies, CA, USA).
2.2. Microarray analysis
Synthetic polynucleotides (80-mers), representing 31 917 hu-
man transcripts, (MicroDiagnostic, Tokyo, Japan) were arrayed by
using a custom arrayer. Microarray analyses were performed as
previously described [13], and detailed method is described in
the Supplementary method 1. All the data in accordance with the
MIAME guideline were deposited at DDBJ via CIBEX database
(http://cibex.nig.ac.jp/index.jsp) in Accession Numbers CBX132.
To identify genes demonstrating signiﬁcant changes in expression,
t-test was performed between the 0-day sample (negative control)
and each RA time point sample (P < 0.01). Among the extracted
genes, we further selected those genes that exhibited differences
greater than 1.0 between the mean averages of log ratios for the
two sample groups.
2.3. Analysis of splicing patterns and functional classiﬁcation
of cDNAs by gene ontology (GO)
Sequences of proteins encoded by the transcripts of 358 genes
selected in this paper and 24 210 human RefSeq were categorizedby GO (http://www.geneontology.org/), detailed method for GO
classiﬁcation is described in the Supplementary method 2. The
splicing patterns of the selected genes were analyzed by using
the information available in the FLJ Human cDNA Database ver.
3.0 as described previously [11]. For analyzing the N-terminus
splicing patterns, we only used our FLJ ESTs constructed by an opti-
mized oligo-capping method, 90% or more of which contained the
transcription start site (TSS) [10,11]. In our analysis, we only fo-
cused on the protein-coding transcripts, and ignored a lot of non-
coding RNAs and mRNAs in which AS occurred only in the untrans-
lated region [14].
2.4. Quantitative real-time PCR analysis
Synthesis of template cDNA, performance of real-time PCR and
design of primers were performed as previously described [11],
and detailed method is described in the Supplementary method
3. The expression values of individual genes were calculated by
comparing their Ct values to that of the control using the RQ soft-
ware (Life Technologies). And the expression levels of genes were
normalized with respect to that of the human glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and were represented in log2
base. Samples were run in triplicates and the data shown are aver-
age of three experiments.
3. Results
3.1. Overview of RA-induced alteration in expression of genes in NT2
cells and functional classiﬁcation of the selected genes by GO
First, to understand the functions of genes during neurodiffer-
entiation, it was necessary to identify the genes whose expression
levels altered upon RA stimulation. Based on the results of previous
studies [15,16], we reasoned that the expression levels of many
genes would alter within 7 days of stimulation with RA. Accord-
ingly, we compared the gene expression proﬁles of the 0-, 1-, 2-
and 7-day RA-stimulated NT2 cells, and consequently obtained
40, 106 and 340 probes (Fig. 1), respectively, whose expression ra-
tios changed over 1.0 in log 2 scale (P < 0.01). We eventually ob-
tained a total of 423 probes by merging the expression level
difference data for each RA-stimulation time point, and these re-
sults are summarized in Supplementary Table 1. In the 7-day RA-
stimulated NT2 cells, the expression levels of the known neurodif-
ferentiation markers NEF3 and neuropilin 2 (NRP2) [17,18] in-
creased by ninefold and threefold, respectively, (Supplementary
Fig. 1), whereas the expression levels of MAP2 and MAPT (Tau),
known as later stage nerve differentiation markers [19], did not
change more than 1.5-fold (Supplementary Fig. 2), suggesting that
these RA-stimulated cells underwent neuronal differentiation, but
were not at the later nerve differentiation stage. Furthermore, the
expression level of the novel tumor progression marker adreno-
medullin (ADM), which is known to be up-regulated in neuroendo-
crine carcinomas [20], in the 7-day RA-stimulated cells decreased
to one-third of that of the control cells (Supplementary Fig. 1), sug-
gesting that these cells lost their carcinoma phenotype. Thus, by
using this experimental system one could identify genes involved
in neuronal differentiation and also could determine the underly-
ing cause of a disease. Our results of DNA microarray analyses sug-
gest that a large number of genes might be involved in the
neuronal differentiation process. Thus, to understand the mecha-
nism of neuronal differentiation, it is important to analyze func-
tions of these genes and ﬁnd correlation among them.
Next, it was necessary to identify genome loci of the selected
423 probes. Analysis of these 423 selected probes, as described
previously [11], led to the identiﬁcation of 358 protein-coding
Fig. 1. Comparison of gene expression proﬁles of control and RA-induced NT2 cells. Gene expression proﬁles of RA-treated cell data after ﬁltering out the control cell data as
described under Materials and methods. (A) 1-day, (B) 2-day and (C) 7-day samples, included 40, 106, 340 probes, respectively. (Lists of genes are shown in Supplementary
Table 1). Columns and rows indicate RA time point samples and genes, respectively. Genes and samples are aligned in the order deﬁned by the results of the clustering
analysis. The color bar represents the grades of the relative expression levels: increase, red; decrease, blue.
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ing to GO classiﬁcation to predict their putative functions. As
shown in Table 1, majority of the selected genes were classiﬁed un-
der the GO molecular function categories ‘‘transcription regulator
activity”, ‘‘ligase activity” and ‘‘ion binding”. Most genes belonging
to the ‘‘ligase activity” and ‘‘ion binding” categories showed altered
expression levels in 7-day sample (Supplementary Table 3), and
they are most likely the candiate genes that are involved in the
neurodifferentiation. Eighteen genes belonging to the ‘‘transcrip-
tion regulator activity” category were identiﬁed as transcription
factors. Because expression levels of these transcription factor
genes changed in all three RA-stimulated samples (Supplementary
Fig. 3), we thought they might regulate expression of other genes
related to neurodifferentiation. Therefore, we analyzed them in
more detail (see below).
3.2. mRNA diversity of RA-induced genes
We have previously found that many genes show tissue-speciﬁc
splicing patterns [11]. Therefore, we next analyzed the mRNAdiversity in 358 selected genes using our FLJ Human cDNA Data-
base. Consequently, we obtained 274 genes (77% of selected
genes) producing multiple protein-coding transcripts as a result
of AS (Supplementary Fig. 4 and Supplementary Table 2).
First, we evaluated the type of splicing using reliable tran-
scripts. To exclude the unreliable transcripts from the immature
mRNA and genomic DNA, reliability of mRNA was evaluated by
using huge number of the human EST data. As a result, we found
136 genes producing multiple protein-coding transcripts using
alternate N-terminus (Alt. N-term) and 59 genes producing multi-
ple protein-coding transcripts using alternate C-terminus (Alt. C-
term). Additionally, there were 26 genes producing multiple pro-
tein-coding transcripts by using alternate use of both N- and C-ter-
minuses. We have previously found that alternative TSSs were
shown to be utilized for tissue-speciﬁc expression [10,11], and
there were demonstrated relationship between the TSS selectivity
and mechanism of transcription for some genes [21,22]. Therefore,
we next analyzed the mRNA diversity of 59 genes each one of
which produced multiple protein-coding transcripts by using Alt.
C-term.
Table 1
GO functional classiﬁcation of 358 genes selected from DNA microarray analysis.
Functional category (GO: molecular function) Number of matched genes
Selected genes % RefSeq %
(358 genes) (24 210 cDNAs)
Binding Nucleic acid binding 25 (14.4) 706 (8.9)
Nucleotide binding 20 (11.5) 1047 (13.2)
Ion binding 12 (6.9) 245 (3.1)
Protein binding 9 (5.2) 450 (5.7)
Other bindings 3 (1.7) 304 (3.8)
Catalytic activity Transferase activity 19 (10.9) 808 (10.2)
Hydrolase activity 15 (8.6) 902 (11.3)
Ligase activity 9 (5.2) 107 (1.3)
Other catalytic activity 11 (6.3) 653 (8.2)
Transcription regulator activity 18 (10.3) 364 (4.6)
Signal transducer activity 12 (6.9) 879 (11.0)
Transporter activity 11 (6.3) 997 (12.5)
Structural molecule activity 4 (2.3) 163 (2.0)
Enzyme regulator activity 3 (1.7) 142 (1.8)
Others 3 (1.7) 193 (2.4)
Total 174 7960
Total refers to the number of cDNAs used for the classiﬁcation of molecular function. We categorized each cDNA used for identifying the genomic regions of extracted 423
probes. Results obtained using the cDNAs transcribed from the same genomic region were merged. We categorized 24 210 human RefSeq and identiﬁed 20 072 protein-
coding genes. Results obtained using the human RefSeq transcribed from the same genomic region were also merged. If an encoded protein was predicted to belong to two or
more categories, it was counted every time.
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script, and succeeded in making speciﬁc primers for 30 genes (Sup-
plementary Table 4). Using these speciﬁc primers, we then
performed quantitative real-time PCR analysis to examine the
expression proﬁles of the protein-coding transcripts produced by
each one of the 30 genes (Supplementary Table 5). Results ob-
tained for 4 genes in the ‘‘transcription regulator activity” category
are described in Section 3.3 and results for the remaining genes are
summarized in Supplementary Table 6(further detailed results are
described in Supplementary analysis results). In the case of 12
genes, the expression proﬁles of the protein-coding transcripts
produced by each one of them were different. The RA-induced
change in the expression level of the soluble-form protein
encoding transcript s9NRP2 (NM_201264.1) [18] was smaller than
the change in the expression levels of the membrane-form protein
encoding transcripts NRP2a (NM_003872.2) and NRP2b
(NM_018534.3) (Supplementary Fig. 5A). In the case of erythrocyte
membrane protein band 4.1 like 5 (EPB41L5), the expression of
NM_020909.2 transcript, which encodes a protein known to bind
to paxillin through its C-terminus [23], was up-regulated, whereas
the expression level of BC032822.2 transcript, which encodes for a
protein lacking the C-terminus paxillin binding site, did not change
(Supplementary Fig. 5B). In the case of collagen triple helix repeat
containing 1 (CTHRC1), the expression level of NM_138455.2 tran-
script, which encodes for a protein that is known to act as a core-
ceptor in theWnt-PCP pathway [24], increased by 32-fold, whereas
the expression level of FLJ57590 transcript, which encodes a pro-
tein lacking the C-terminus binding domain, increased by only
fourfold after 7-day RA induction (Supplementary Fig. 5C). Inter-
estingly, the expression level of NM_138455.2 decreased by two-
fold, whereas the expression level of FLJ57590 increased by 11-
fold after 35-day of incubation with RA (Supplementary Fig. 6A).
The transcripts produced by the nephronophthisis 1 (juvenile)
gene, NM_000272.2 and NM_207181.1, showed similar expression
patterns until day 7, and then the expression level of NM_207181.1
decreased, while the expression level of NM_000272.2 increased
(Supplementary Fig. 6B). Notably, out of the 14 genes that showed
similar expression patterns until 7-day, we found 7 genes in which
the up or down-regulation ratios between the two transcripts pro-
duced from each gene were different at a later stage (Supplemen-
tary Table 6). Among these genes, there were two genes with
unknown function, namely WD repeat domain 74 (SupplementaryFig. 6C) and DENN/MADD domain containing 5B (Supplementary
Fig. 6D).
Next, we analyzed the relationship between the mRNA diver-
sity and function of genes by utilizing the results of AS typing
and GO classiﬁcation (Supplementary Table 7). All genes in the
‘‘ligase activity” category produced multiple protein-coding tran-
scripts. We predicted that multiple protein-coding transcripts
having variable regions were required for neurodifferentiation.
Ten genes in the ‘‘ion binding” category produced multiple pro-
tein-coding transcripts, 6 of which had alternative N-terminus,
suggesting that these genes were controlled by transcription
mechanism. The mRNA diversity of 18 genes in the ‘‘transcription
regulator activity” category were analyzed in more detail (see be-
low). We believe the mRNA diversity and gene function are corre-
lated [25], and therefore, it is imperative to understand this
relationship in order to identify the genes that are speciﬁcally in-
volved in neurodifferentiation.
3.3. Analysis of expression patterns of selected transcription factors
We analyzed the mRNA diversity of 18 transcription factor
genes which were classiﬁed under ‘‘transcription regulator activ-
ity” by GO analysis (Table 1, Supplementary Fig. 3), as transcrip-
tion factors regulate various genes, and transcription factor genes
producing multiple transcripts are known to work mutually as
regulating factors in transcription [26]. Out of the 18 transcription
factor genes examined, we found that 12 genes - namely ets var-
iant 1 (ETV1), ets variant 4 (ETV4), ets variant gene 5 (ETV5),
HNF1 homeobox B (HNF1B), homeobox A2 (HOXA2), homeobox
A3 (HOXA3), paired box 6 (PAX6), paternally expressed 3
(PEG3), POU class 5 homeobox 1 (POU5F1), RARB, regulatory fac-
tor X, 2 (inﬂuences HLA class II expression) (RFX2) and zinc ﬁnger
protein 483 (ZNF483) – produced multiple protein-coding tran-
scripts by AS (Supplementary Fig. 7). Using primers designed
against the speciﬁc regions of protein-coding transcripts (Supple-
mentary Table 4), we performed quantitative real-time PCR anal-
ysis to examine the expression proﬁles of the protein-coding
transcripts produced by each one of the 12 transcription factor
genes (Supplementary Table 8). The results are summarized in
Table 2, and results obtained on 6 of these genes are discussed
below (further detailed results are described in Supplementary
analysis results).
Table 2
Quantitative evaluation of 12 transcription factors by real-time PCR.
AS pattern Gene symbol cDNA name Change in expression level compared to the 0-day sample Expression pattern
1-day 2 day 7 day
Alt. N-terminus ETV1 NM_004956.3 ± ; ± Differ
FLJ50494 ± ± ;
ETV4 NM_001986.1 ± ; ; Same
BC007242.1 ± ; ;
ETV5 NM_004454.1 ; ; ; Differ
FLJ56169 ± ; ;
HOXA3 NM_030661.3 "" """ """ Differ
NM_153632.1 ± " "
PAX6 NM_000280.2 " " "" Same
FLJ36930 " " ""
POU5F1 NM_002701.3 ± ± ; Differ
NM_203289.3 ± ; ;
RARB NM_000965.2 " "" "" Differ
FLJ56241 " " "
Alt. C-terminus HNF1B NM_000458.1 " "" "" Same
NM_006481.1 " "" ""
HOXA2 NM_006735.3 """ """ """ Differ
FLJ39423 "" "" """
PEG3 NM_006210.1 ± ± " Differ
NM_015363.3 ± ± ±
ZNF483 NM_133464.1 ± ; ; Differ
FLJ35492 ± ± ;
Alt. cassette-exon RFX2 NM_000635.2 ± " " Same
FLJ53376 ± " "
Out of the 18 transcription factors, 6 transcription factors – namely GATA6 (NM_005257.3), GBX2 (NM_001485.2), HESX1 (NM_003865.1), HOXB2 (NM_002145.2), HOXB4
(NM_024015.3) and HOXC4 (NM_014620.2) – produced only single protein-coding transcripts. They are not shown in this table. Symbols used to indicate differences of mean
averages of log 2 ratios between the control (0-day) and experimental samples (1-day, 2-day and 7-day): ‘‘±”, >1/2 but <twofold; ‘‘;”, >1/100 but 61/2; ‘‘"”, Ptwofold but
<100-fold; ‘‘""”, P100-fold but <1000-fold; and ‘‘"""”, P1000-fold.
A. Wakamatsu et al. / FEBS Letters 584 (2010) 4041–4047 4045In the case of PEG3 (Fig. 2A), HOXA2 (Fig. 2B) genes, we found
that the regulation of mRNA diversity was controlled by the
expressions level. Transcript NM_006210.1 encodes for PEG3 and
transcript NM_015363.3 encodes for ZIM2 originated from one
genome locus [27]. The expression of NM_006210.1 (PEG3) was
preferentially up-regulated than the expression of NM_015363.3
(ZIM2) (Fig. 2A), suggesting that NM_006210.1 (PEG3) might be
more necessary for neuronal differentiation. Since the tumor sup-
pressor activity of PEG3 was shown to be due to the loss of cell pro-
liferation of cancer cells [28], its expression level is expected to
increase during the RA-induced neuronal differentiation of NT2
cells. Thus, our results suggest that protein-coding transcripts
produced by a gene is regulated by AS. Likewise, the up-regulation
ratios of the two transcripts, HOXA2 (NM_006735.3) and FLJ39423,
were signiﬁcantly different (Fig. 2B). FLJ39423, which was identi-
ﬁed as the splicing variant of HOXA2 resulting from Alt. C-term
utilization, was predicted to lack the homeobox domain (Supple-
mentary Fig. 7I). These results suggest preferential need for the
transcript containing functional domain during neuronal differen-
tiation. We also obtained similar results in the case of RARB gene
(Supplementary Table 8).
As shown in Fig. 2C, RA-induced increase in the expression lev-
els of two transcripts, NM_000458.1 and NM_006481.1, produced
from the HNF1B gene by utilizing Alt. C-terms were very similar.
Similar results were observed with PAX6 and RFX2 genes (Supple-
mentary Table 8), suggesting that both transcripts form each one of
these genes might be needed for the neuronal differentiation, and
they all were probably regulated by the same transcriptional regu-
latory mechanism.
From the expression proﬁles of two transcripts of the POU5F1
gene (Fig. 2D), resulting from the Alt. N-term utilization –
NM_002701.3 known as OCT4A and NM_203289.3 known as
OCT4B [29], we also found that the regulation of mRNA diversity
was controlled both by the expressions level and the transcription
time. The expression level of NM_203289.3 (OCT4B) decreasedmore rapidly than that of NM_002701.3 (OCT4A). We suggest that
the decrease in the expression level of OCT4B was more impor-
tant for the early stage of neuronal differentiation because its
down-regulation was induced ﬁrst. Similar results were observed
with the ZNF483 gene (Supplementary Table 8). Since the unique
regions of NM_002701.3 (OCT4A) and NM_203289.3 (OCT4B) cho-
sen for the expression analysis were located only in their N-ter-
minus, we suggest that the expression levels of both transcripts
were regulated by different transcription mechanisms during
neurodifferentiation.
Finally, we report on two other genes, HOXA3 and ETV5, of un-
known functions. As shown in Fig. 2E, the up-regulation ratios and
the time required to initiate changes in the expression level were
different for two transcripts produced from the HOXA3 gene,
NM_030661.3 and NM_153632.1, which differed in their N-termi-
nal regions. We speculated that NM_030661.3 played a more
important role than NM_153632.1 in neuronal differentiation.
We next examined expression of ETV5 (NM_004454.1) and
FLJ56169, the latter of which was previously identiﬁed as the splic-
ing variant of the former [11], and they differ in the N-terminus as
a result of ﬁrst exon variation. The expression level of
NM_004454.1 decreased rapidly than the expression level of
FLJ56169 (Fig. 2F). Interestingly, the expression level of
NM_004454.1 increased back to the control (0-day) level in the
35-day sample (Supplementary Table 8) whereas the expression
level of FLJ56169 increased back to the control level after 14-day
and then increased by fourfold after 35-day incubation with RA.
Based on these results, we suggest that whereas a decrease in
the expression level of NM_004454.1 was needed at an early stage
of neuronal differentiation, an increase in the expression level of
FLJ56169 was needed at a later stage. In the case of ETV1 gene
(Supplementary Table 8), we obtained similar result as ETV5 gene.
The transcripts produced by the ETV4 gene showed similar expres-
sion patterns as ETV5 gene until day 7, and then the expressions of
the ETV4 transcripts were up-regulated differently than those of
Fig. 2. Quantitative evaluation of selected 6 transcription factors by real-time PCR. Expression levels of two transcripts produced by AS from each gene were analyzed by real-
time PCR, and were represented in log 2 base. The data were normalized with respect to that of the human GAPDH. Name of the genes: (A) PEG3, (B) HOXA2, (C) HNF1B, (D)
POU5F1, (E) HOXA3, (F) ETV5. Schematic views of selected genes: boxes, exons; gray lines, introns; black boxes, coding regions; white boxes, untranslated regions; red or navy
bars, ampliﬁed regions by real-time PCR.
4046 A. Wakamatsu et al. / FEBS Letters 584 (2010) 4041–4047the ETV5 transcripts (Supplementary Table 8). Thus, we found that
the transcripts produced by the members of the ETS domain fam-
ily, the ETV5, ETV4 and ETV1 genes, showed similar expression
patterns.
4. Discussion
To know the underlying causes of diseases related to neuronal
differentiation, we analyzed the expression patterns of genes in
NT2 cells that were induced by RA to differentiate into neurons
[12]. Consequently, we identiﬁed 358 RA-responsive genes follow-
ing 7-day induction with RA. GO classiﬁcation of selected genes re-
vealed three major functional groups (Table 1). Eighteen genes
belonging to the ‘‘transcription regulator activity” category were
identiﬁed as transcription factors. Most genes under the categories,
‘‘ligase activity” and ‘‘ion binding”, were related to cell properties
(Supplementary Table 3).
AS of a gene results in multiple protein-coding transcripts [1–3].
AS particularly occurs and plays an important role in imparting
biological and functional diversity associated with neuronal differ-
entiation [4,5]. To understand functions of the RA-responsive
genes, it was necessary to analyze their mRNA diversity. Our anal-
ysis using the FLJ Human cDNA Database ver. 3.0 [11] revealed that
about 77% of our selected genes produced multiple protein-coding
transcripts by AS (Supplementary Fig 4 and Supplementary Table
2). We have previously used the FLJ Human cDNA Database to reli-
ably evaluate mRNA diversity of genes and correlated mRNA diver-
sity with gene function.We examined what effect neuronal differentiation has on the
expression of alternatively spliced transcripts of the 18 RA-respon-
sive transcription factor genes (Table 2). These transcription factor
genes are expected to play key roles in neuronal differentiation. In
PEG3 (Fig. 2A), HOXA2 (Fig. 2B) and RARB (Supplementary Table 8)
genes, expression of one of the two transcripts was preferentially
up-regulated than the other one, suggesting that they might be re-
quired for neurodifferentiation. On the other hand, RA similarly in-
duced the expression of two transcripts from each one of the
HNF1B (Fig. 2C), PAX6, ETV4 and RFX2 (Supplementary Table 8)
genes, this observation predicts that both transcripts were needed
in neurodifferentiation. Further studies are needed to conﬁrm
whether these two transcripts are indeed play any role in neurodif-
ferentiation. In the case of POU5F1 (Fig. 2D), HOXA3 (Fig. 2E), ETV5
(Fig. 2F), ETV1 and ZNF483 (Supplementary Table 8) genes, not
only the up-regulation ratios of two transcripts produced from
each gene, but also the time required to initiate changes in their
expression level were different. We speculate that the mechanism
by which these genes could selectively produce a given transcript
might be related to neurodifferentiation. Especially in HOXA3
(Fig. 2E) and ETV5 (Fig. 2F) genes, because the two transcripts pro-
duced by each one of these two genes differed only in their N-ter-
minus, it strongly suggested that their N-terminus regions have
some yet to be determined key function in neuronal differentia-
tion. Since these N-terminus ends also included TSS, we suggest
that their speciﬁc expression were controlled by transcriptional
mechanism. Thus, by comparing expression proﬁles of different
transcripts, we obtained new functional information on genes.
A. Wakamatsu et al. / FEBS Letters 584 (2010) 4041–4047 4047We also analyzed the expression proﬁles of genes that produced
multiple protein-coding transcripts by using alternate C-terminus.
In some cases, we found that the RA-induced changes in the expres-
sion of transcripts produced by the gene were different (Supple-
mentary Table 6). Genes included in this category were some of
the disease-related genes – for example, NRP2 gene thought to be
related to tumor progression [18,30], and EPB41L5 gene is thought
to be related to cancer cell invasion [23]. These results suggested
that any approach that includesmultiple protein-coding transcripts
in the analysis processwould be important for furthering functional
analysis of genes. We also found that in the case of the CTHRC1
gene, the expression level of the transcript, which codes for a factor
in the Wnt-PCP pathway [24], was induced at the early stage,
whereas the expression level of FLJ57590 transcript that lacks the
C-terminus binding site for the Wnt-PCP pathway factor was in-
duced at a later stage following RA induction (Supplementary
Fig. 6A). We think that the protein encoded by the FLJ57590 tran-
script is most likely not related to theWnt-PCP pathway, but might
be related to the canonical Wnt-signaling pathway.
Not only genetic backgrounds but environmental conditions
might contribute to the mRNA diversity. Identiﬁcation of the risk
factor responsible for the mRNA diversity would, therefore, be an
important step for discovering new drugs. Results described in this
study tend to suggest that the mRNA diversity of genes might play
important roles in neuronal differentiation induced by the environ-
mental conditions, such as RA. Our study also suggest that by
investigating how genes are alternatively spliced during neuronal
differentiation might contribute signiﬁcantly for understanding
of the mechanism of neuronal differentiation. Accumulating more
data on the mRNA diversity of genes using approaches similar in
this study will not only reveal the underlying mechanism by which
genes produce speciﬁc protein-coding transcripts in response to
various factors but will also contribute to the uncovering of new
functions of genes. Additionally, more and better we understand
AS and its contribution to diseases, we might be able to identify
candidate genes as novel targets for new drugs.
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